CAS: 442908-10-3
Ref: IN-DA0039VL
| 2mg | 50.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 127.00 € | ||
| 25mg | 200.00 € | ||
| 100mg | 693.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 29 Apr 2025
![3-(4-Amino-3-Methylbenzyl)-7-(Furan-2-Yl)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-5-Amine](https://static.cymitquimica.com/products/54/thumb/OR1023107.jpg)
3-(4-Amino-3-Methylbenzyl)-7-(Furan-2-Yl)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-5-Amine
CAS:442908-10-3
Purity:
98%
Molecular weight:
321.34g/mol
Ref: 54-OR1023107
| 1g | 2,005.00 € | ||
| 100mg | 490.00 € | ||
| 250mg | 819.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
Ref: 54-BUP07740
| 25mg | 326.00 € | ||
| 50mg | 523.00 € | ||
| 100mg | 779.00 € | ||
| 500mg | 1,531.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
Vipadenant
CAS:442908-10-3
Vipadenant (CEB-4520)(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for …
Formula:
C16H15N7O
Purity:
97.25% - 97.36%
Color and Shape:
Solid
Molecular weight:
321.34
Ref: TM-T2373
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 210.00 € | ||
| 50mg | 350.00 € | ||
| 100mg | 522.00 € | ||
| 500mg | 1,130.00 € | ||
| 1mL*10mM (DMSO) | 359.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
Vipadenant
CAS:442908-10-3
Vipadenant is a new drug that has been developed for the treatment of cancer. It …
Formula:
C16H15N7O
Purity:
Min. 95%
Molecular weight:
321.34 g/mol
Ref: 3D-SSA90810
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
